Sagimet Biosciences (SGMT) Current Deferred Tax Assets (2023 - 2024)
Sagimet Biosciences has reported Current Deferred Tax Assets over the past 2 years, most recently at $306000.0 for Q3 2024.
- Quarterly results put Current Deferred Tax Assets at $306000.0 for Q3 2024, changed N/A from a year ago — trailing twelve months through Sep 2024 was $306000.0 (changed N/A YoY), and the annual figure for FY2023 was $323000.0, changed.
- Current Deferred Tax Assets for Q3 2024 was $306000.0 at Sagimet Biosciences, down from $323000.0 in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for SGMT hit a ceiling of $2.6 million in Q2 2023 and a floor of $306000.0 in Q3 2024.